Trial Profile
Bendamustine as first-line treatment in patients with advanced indolent non-Hodgkin lymphoma and mantle cell lymphoma in German routine clinical practice
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2015
Price :
$35
*
At a glance
- Drugs Bendamustine (Primary)
- Indications Mantle-cell lymphoma; Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- Sponsors Mundipharma GmbH
- 09 Nov 2015 New trial record